Posts Categorized: News
A U of T Engineering student team working on synthetic biology research and innovation has achieved its best results to date at the International Genetically Engineered Machine (iGEM) competition, with a platform to counter so-called superbugs that resist antibiotic treatment. With the support of Professors Michael Garton and Freeman Lan (both BME), the team started working with plasmids from E. coli bacteria to see if they could generate new sequences and validate their functionality, both computationally and in the wet lab.
Three faculty members at the University of Toronto’s Institute of Biomedical Engineering (BME) have been awarded Canada Research Chairs (CRCs) by the Canadian Institutes of Health Research (CIHR) and the Natural Sciences and Engineering Research Council (NSERC).
Professor Alison McGuigan (ChemE, BME) has earned an Arthur B. McDonald Fellowship from the Natural Sciences and Engineering Research Council (NSERC).
Professor Milica Radisic (BME, ChemE) has received this year’s John C. Polanyi Award from the Natural Sciences and Engineering Research Council (NSERC).
Last week, students from the class of 2T4 walked across the stage at Convocation Hall and became the latest engineering alumni. Nevena Musikic, Amber Xue, and Alyssia Sanchez shared their graduate experiences in this video.
Professor Leo Chou has been awarded $130,000 in funding from The Cancer Research Society (CRS) to propel forward an ambitious project aiming to boost the effectiveness of cancer vaccines. This award places him among 100 distinguished Canadian recipients this year, each selected to push boundaries in cancer research with innovative solutions.
BME alum James Lazarovits' (BME 2019) startup Archon Biosciences debuts with $20M to advance Nobel-inspired protein technology in cancer treatment.
Researchers from the Institute of Biomedical Engineering at the University of Toronto have identified a novel approach to potentially slow cancer progression by targeting a key enzyme that influences cancer-associated fibroblasts (CAFs).
A recent study led by researchers at the University of Toronto sheds new light on a crucial challenge in the field of nucleic acid drug delivery: how to make lipid nanoparticles (LNPs) break down more quickly in the body. This discovery could pave the way for medicines that can be administered more frequently and with fewer side effects.
Researchers from the Institute of Biomedical Engineering at the University of Toronto have developed a novel MRI contrast agent that may enhance the early detection of inflammatory diseases by targeting nitric oxide (NO), a key molecule involved in the body’s immune response.
Showing 81 - 90 of 582 results